Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: The health department said at least 16 patients admitted to the 210-bed Mount Carmel Grove City hospital after its opening April 28 have been diagnosed with Legionnaires’. The disease is a severe form of pneumonia that’s caused by inhaling tiny water droplets containing the legionella bacteria. One of the patients, a 75-year-old woman, died. Hospital president Sean McKibben said in a statement Thursday that the disease outbreak happened because of inadequate disinfection of the hot water system prior to the hospital’s opening. He said a permanent supplemental disinfection system with constant monitoring and controls has been installed. ___ Information from: The Columbus Dispatch, http://www.dispatch.com
[A]: Outbreak of Legionnaire’s blamed on hot water system.


[Q]: Evolocumab met the main goal of a late-stage trial titled RUTHERFORD-2 by lowering “bad” LDL cholesterol levels when tested against a placebo on 329 patients. Amgen, the world’s biggest biotechnology company, is testing evolocumab widely on a variety of subpopulations. The RUTHERFORD-2 study included patients with familial hypercholesterolemia, an inherited condition that causes high levels of “bad” LDL cholesterol starting at birth. Specifically, patients in the study had heterozygous familial hypercholesterolemia, which is one of the most common genetic disorders affecting about one out of every 300 to 500 people worldwide, according to Amgen. The company on Tuesday reported positive results from a fourth late-stage study of evolocumab, for which it plans to begin seeking approvals this year. The drug is intended for people who cannot tolerate widely used statins, or who are unable to get their LDL levels low enough despite using high potency statins, such as AstraZeneca’s Crestor. Amgen’s shares closed at $120.89 on the Nasdaq on Thursday.
[A]: Amgen's cholesterol fighter succeeds in fifth late-stage study.


[Q]: There was no information about the respective financial costs of the treatments for prostate cancer discussed. Costs would include treating the double digit rates of incontinence and erectile dysfunction in these younger men who do have surgery. The surgery may help them live longer, but many, especially since younger at time of surgery, live decades with these potential harms and folllowup costs of the surgical choice. This should get at least a line in such stories. The story did a good job of identifying those men (i.e. those younger than 65 at the time of symptomatic prostate cancer ) who reduced their chance of dying by having surgery to remove their prostate. Good use of absolute numbers. The story provided readers with insight that for men younger than 65 years of age at the time of diagnosis, there was a significantly greater chance of dying in the men who did not have immediate surgery to remove their prostate gland. The story also described that a substantial proportion of men who did have surgery to remove their prostate gland experienced sexual and/or urinary problems. Best job of the three stories we reviewed in quantifying harms. The story did a fine job providing information about where the study reported on had been published,  the number of men and the length of time they had been studied, their age,  the two treatments the men were randomly assigned to, as well as background information on the first indication that the men had prostate cancer. The story did not engage in overt disease mongering. The story included quotes from the clinician who wrote the editorial which accompanied the study reported on as well as another clinician without direct ties to the study detailed in the story. The story provided some of the comparative information from the study reported on about surgery to remove the prostate and waiting to see if prostate cancer would progress before undergoing active treatment. In addition, the story included a list of the common utilized approaches to active treatment of prostate cancer. The story was clear about the fact that the overwhelming majority of men in the study had had their prostate cancer first detected because of symptoms which is means that they were in a different place in the prostate cancer timeline than men whose first inkling about prostate cancer is that they have an elevated PSA level in their blood. So it describes practices in Europe many years ago which are different than current care in the US. The story was clear the the men in the study reported on had been part of the investigation which started in 1989. The story did not rely on a press release.
[A]:
Study: Prostate cancer surgery helps younger men